Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients
Clinical trial NCT03280056 · COMPLETED
Trial details
- NCT number
- NCT03280056
- Sponsor
- Brainstorm-Cell Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2020-09-29
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.